Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

528 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction.
Savarese G, Edner M, Dahlström U, Perrone-Filardi P, Hage C, Cosentino F, Lund LH. Savarese G, et al. Among authors: cosentino f. Int J Cardiol. 2015 Nov 15;199:415-23. doi: 10.1016/j.ijcard.2015.07.051. Epub 2015 Jul 21. Int J Cardiol. 2015. PMID: 26247798
Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes.
Savonitto S, Morici N, Nozza A, Cosentino F, Perrone Filardi P, Murena E, Morocutti G, Ferri M, Cavallini C, Eijkemans MJ, Stähli BE, Schrieks IC, Toyama T, Lambers Heerspink HJ, Malmberg K, Schwartz GG, Lincoff AM, Ryden L, Tardif JC, Grobbee DE. Savonitto S, et al. Among authors: cosentino f. Diab Vasc Dis Res. 2018 Jan;15(1):14-23. doi: 10.1177/1479164117735493. Epub 2017 Oct 20. Diab Vasc Dis Res. 2018. PMID: 29052439 Free article. Clinical Trial.
Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design.
Savarese G, Settergren C, Schrage B, Thorvaldsen T, Löfman I, Sartipy U, Mellbin L, Meyers A, Farsani SF, Brueckmann M, Brodovicz KG, Vedin O, Asselbergs FW, Dahlström U, Cosentino F, Lund LH. Savarese G, et al. Among authors: cosentino f. Int J Cardiol. 2020 Aug 15;313:76-82. doi: 10.1016/j.ijcard.2020.04.068. Epub 2020 Apr 30. Int J Cardiol. 2020. PMID: 32360702 Free article.
Use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry.
Becher PM, Schrage B, Ferrannini G, Benson L, Butler J, Carrero JJ, Cosentino F, Dahlström U, Mellbin L, Rosano GMC, Sinagra G, Stolfo D, Lund LH, Savarese G. Becher PM, et al. Among authors: cosentino f. Eur J Heart Fail. 2021 Jun;23(6):1012-1022. doi: 10.1002/ejhf.2131. Epub 2021 Mar 2. Eur J Heart Fail. 2021. PMID: 33599357 Free article.
High awareness of diabetes as a key cardiovascular risk factor among healthcare professionals but suboptimal treatment: Results from a survey of the European Association of Preventive Cardiology.
Hansen D, Mellbin L, Cosentino F, De Bacquer D, Grobbee D, Van Ryckeghem L, Standl E, Beulens JWJ. Hansen D, et al. Among authors: cosentino f. Eur J Prev Cardiol. 2021 Dec 29;28(15):e19-e21. doi: 10.1177/2047487320911845. Eur J Prev Cardiol. 2021. PMID: 33611354 No abstract available.
Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitors.
Herrington WG, Savarese G, Haynes R, Marx N, Mellbin L, Lund LH, Dendale P, Seferovic P, Rosano G, Staplin N, Baigent C, Cosentino F. Herrington WG, et al. Among authors: cosentino f. Eur J Heart Fail. 2021 Aug;23(8):1260-1275. doi: 10.1002/ejhf.2286. Epub 2021 Jul 20. Eur J Heart Fail. 2021. PMID: 34184823 Free article. Clinical Trial.
528 results